Aspirin does not cause rupture of intracranial aneurysms, but may increase the risk of rebleeding in those who have already had a rupture.
It has been shown that aspirin use prevents the occurrence of aneurysmal subarachnoid hemorrhage and that the dose of aspirin taken is also negatively associated with the occurrence of aneurysmal subarachnoid space, with higher doses being more protective than lower doses. However, aspirin also increases the risk of rebleeding, possibly related to the anticoagulant effect of aspirin.
Aspirin is a classic nonsteroidal anti-inflammatory drug that provides antipyretic and analgesic effects by inhibiting some specific enzymes in the body, and the drug also has some antiplatelet coagulation effects.
Intracranial aneurysms that are not amenable to surgery may be managed with the use of this drug. However, whether the specific need to use the clinician needs to be based on the condition of the comprehensive judgment, prohibit unauthorized use of the drug.
It is recommended that patients with aneurysms go to the hospital in time for consultation and active treatment under the guidance of the doctor.